Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)

Sponsor
Johns Hopkins University (Other)
Overall Status
Completed
CT.gov ID
NCT00353795
Collaborator
Northwestern University (Other)
179
2
35
89.5
2.6

Study Details

Study Description

Brief Summary

The overall goal of this study is to use MRI to:
  • Examine the relationship between known risk factors for cardiovascular disease and coronary artery wall thickness;

  • Examine the relationship between coronary artery wall thickness and other markers of subclinical coronary atherosclerosis, such as carotid wall thickness and coronary calcium scores; and,

  • Examine the feasibility of measuring the progression of coronary artery wall thickness over time in a subset of participants.

Condition or Disease Intervention/Treatment Phase
  • Procedure: MR Imaging of the Coronary Arteries
N/A

Detailed Description

Each enrolled participant will undergo MR Imaging of the coronary arteries in conjunction with their routine MESA follow-up visit. The MRI will last approximately 45-60 minutes

Study Design

Study Type:
Interventional
Actual Enrollment :
179 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Coronary Atherosclerosis Evaluation by Arterial Wall MRI
Study Start Date :
Jul 1, 2005
Actual Primary Completion Date :
Jun 1, 2008
Actual Study Completion Date :
Jun 1, 2008

Outcome Measures

Primary Outcome Measures

  1. Mean Coronary Wall Thickness [n/a (cross sectional analysis)]

    Average thickness of the wall of the left anterior descending, right and left main coronary artery measured by magnetic resonance imaging (MRI).

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Prior enrollment in the MESA Study at the Hopkins MESA Field Center or the Northwestern University MESA Field Center

  • Male or Female adult equal to or older than 45 years of age

  • Willing/able to provide informed consent

Exclusion Criteria:
  • Any known contraindications to MRI (i.e. severe claustrophobia, pacemaker, etc.)

  • Metal in the eyes

Contacts and Locations

Locations

Site City State Country Postal Code
1 Northwestern University MESA Field Center Chicago Illinois United States 60611
2 Johns Hopkins MESA Field Center Baltimore Maryland United States 21244

Sponsors and Collaborators

  • Johns Hopkins University
  • Northwestern University

Investigators

  • Principal Investigator: David A Bluemke, MD PhD, Johns Hopkins University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00353795
Other Study ID Numbers:
  • 05-05-23-01
  • 5R01HL078909
First Posted:
Jul 19, 2006
Last Update Posted:
Jun 22, 2010
Last Verified:
Sep 1, 2009

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Participants
Arm/Group Description Participants in the MESA trial (http://www.mesa-nhlbi.org/) randomly selected by the University of Washington Coordinating center who agreed to participate. Enrollment from October 2005 to February 2008
Period Title: Overall Study
STARTED 179
COMPLETED 179
NOT COMPLETED 0

Baseline Characteristics

Arm/Group Title Participants
Arm/Group Description Participants in the MESA trial (http://www.mesa-nhlbi.org/) randomly selected by the University of Washington Coordinating center who agreed to participate. Enrollment from October 2005 to February 2008
Overall Participants 179
Age (Count of Participants)
<=18 years
0
0%
Between 18 and 65 years
179
100%
>=65 years
0
0%
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
61
(9)
Sex: Female, Male (Count of Participants)
Female
90
50.3%
Male
89
49.7%
Region of Enrollment (participants) [Number]
United States
179
100%

Outcome Measures

1. Primary Outcome
Title Mean Coronary Wall Thickness
Description Average thickness of the wall of the left anterior descending, right and left main coronary artery measured by magnetic resonance imaging (MRI).
Time Frame n/a (cross sectional analysis)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Participants
Arm/Group Description Participants in the MESA trial (http://www.mesa-nhlbi.org/) randomly selected by the University of Washington Coordinating center who agreed to participate. Enrollment from October 2005 to February 2008
Measure Participants 179
Mean (Standard Deviation) [mm]
2.0
(0.3)

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Participants
Arm/Group Description Participants in the MESA trial (http://www.mesa-nhlbi.org/) randomly selected by the University of Washington Coordinating center who agreed to participate. Enrollment from October 2005 to February 2008
All Cause Mortality
Participants
Affected / at Risk (%) # Events
Total / (NaN)
Serious Adverse Events
Participants
Affected / at Risk (%) # Events
Total 0/179 (0%)
Other (Not Including Serious) Adverse Events
Participants
Affected / at Risk (%) # Events
Total 0/179 (0%)

Limitations/Caveats

Cross sectional study

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title David Bluemke
Organization NIH
Phone 301 402 1854
Email bluemked@nih.gov
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00353795
Other Study ID Numbers:
  • 05-05-23-01
  • 5R01HL078909
First Posted:
Jul 19, 2006
Last Update Posted:
Jun 22, 2010
Last Verified:
Sep 1, 2009